InsidersTradesSigma
Follow the Thyrocare Tech stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Tech has published 7 public disclosures. Market capitalisation: €95.7bn. The latest transaction was filed on 1 July 2026 (Acquisition). Among the most active insiders: Nikhil Bodhankar. All data is openly available.
7
Insider Decl.
n/a
Thresholds
€3,443
2 ops.
Buy Volume
€8,006
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Thyrocare Tech Strong Buy (bullish), based on 5 analysts. Average price target: ₹649.00.
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,895 of 29,063 companies
61.2
score / 100
Value34
Quality88
FCF yld2.1%
Earn yld1.8%
EV/EBITDA33.8x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations7 total
250 shares@ ₹523.300.0000% mcap100.0% of flowEquityMarket PurchaseSEBI:cac8163240224e50442abe59e781797a1d140798
Canonical exit: 29 Sept 2026 (T+90)
1,000 shares@ ₹549.600.0000% mcap100.0% of flowEquityMarket SaleSEBI:160a8b2be5be4f808bb9bb60815cb3c9b2a7ea6f
200 shares@ ₹550.000.0000% mcap34.7% of flowEquity SharesMarket SaleSEBI:542c2a0c1a0fc282e8ff2dc9c6246c67410ee90e
90 shares@ ₹552.000.0000% mcap15.7% of flowEquity SharesMarket SaleSEBI:49763664477372e5e9aa8c2cfde3893b66429d60
200 shares@ ₹550.000.0000% mcap68.9% of flowEquity SharesMarket SaleSEBI:e374aa37afa8b82f3b0d7cd195bceddac669b314
90 shares@ ₹552.000.0000% mcap31.1% of flowEquity SharesMarket SaleSEBI:352530b7e0fe38f4714f93d4dd9cbc59988f064c
450 shares@ ₹546.50100.0% of flowEquity SharesMarket PurchaseSEBI:0bc61903aea47be541ecd5b3d45888e8252e5dff
Canonical exit: 10 Sept 2026 (T+90)
7 of 7 declarations
关于 Thyrocare Tech
Thyrocare Tech 是一家专门从事诊断和实验室检测服务的公司。它主要在印度市场运营，并在孟买证券交易所上市。